Tyler Stone Wealth Management Organon & Co. Transaction History

Tyler Stone Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $481 - $615	-25 Reduced 25.0%	75 $2,000
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $3,166 - $3,890	100 New	100 $3,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $140,404 - $181,488	-4,611 Closed	0 $0
Q4 2021 Feb 22, 2022	BUY	$28.67 - $37.13 $132,197 - $171,206	4,611 New	4,611 $140,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tyler Stone Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Tyler Stone Wealth Management with notifications on news.